| IκB-ζ (also known as MAIL/INAP) is an atypical member of the IκB family encoded by NFKBIZ, functionally positioned as a nuclear transcriptional regulator that integrates Toll-like receptor and interleukin-1 receptor signaling with selective NF-κB–dependent gene expression in immune and barrier tissues. IκB-ζ contains a C-terminal array of ankyrin repeats that binds preferentially to NF-κB subunits such as p50 and p52, while its N-terminal regulatory region accommodates phosphorylation and interaction motifs that modulate its stability and transcriptional regulatory capacity in response to upstream signals. IκB-ζ expression is induced downstream of MyD88-dependent TLR and IL-1R pathways via an IRAK1/IRAK4- and TRAF6-dependent module that promotes NF-κB–mediated Nfkbiz transcription and a distinct post-transcriptional mechanism that acts through a defined regulatory element in the IκB-ζ mRNA to enhance message accumulation in activated macrophages and other innate immune cells. IκB-ζ associates with NF-κB complexes on κB-containing promoters and functions as a transcriptional co-regulator that enables the induction of a subset of secondary response genes, including proinflammatory mediators such as interleukin-6 and other late-phase NF-κB targets, while repressing or attenuating expression of a different subset of NF-κB-responsive genes, thereby shaping promoter- and context-specific transcriptional outputs and establishing a differential gene expression profile downstream of common upstream cues. Within B cells, IκB-ζ induction follows engagement of the B-cell receptor and TLRs and depends on NF-κB–driven transcription combined with mRNA stabilization, and IκB-ζ supports expression of immunoregulatory genes such as IL-10 and CTLA4, contributes to optimal proliferative responses, and constrains surface costimulatory molecule upregulation under TLR stimulation, indicating a role in balancing activation and tolerance in adaptive immune compartments. IκB-ζ operates as a central node in inflammatory signaling by acting at the chromatin level as a cofactor for NF-κB on specific promoters, by integrating parallel signaling inputs that control its transcription and mRNA stability, and by imposing temporal control over inflammatory gene networks in macrophages, epithelial cells, and B cells, which makes it a critical determinant of how cells respond to persistent or combined innate and adaptive stimuli. Dysregulated IκB-ζ expression or function contributes to chronic inflammatory states and cancer, where constitutive NF-κB activity in certain lymphoma or solid tumor contexts depends on IκB-ζ to sustain a pathogenic transcriptional program, and where increased or ectopic IκB-ζ levels correlate with enhanced survival, inflammatory mediator production, or altered tissue homeostasis. |
